Menu
1 min read · estimated
APPROVED USE
What FDA approved
Adults with metastatic RET fusion-positive NSCLC identified by an FDA-approved test.
LAMPGEN ANALYSIS
Why it matters
This confirms the lung-specific accelerated indication via traditional approval.
What research teams should watch
Distinguish this conversion from the separate same-day tumor-agnostic accelerated approval.
PRIMARY RECORDS